SCHEMBL2491333

SCHEMBL2491333

NN1CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11989092 0.80
SCHEMBL981790 0.78
Water SCHEMBL10814803 0.76
Hydrochloric Acid SCHEMBL2526119 0.76
SCHEMBL25124370 0.74 BRD4 (0.39)
SCHEMBL874304 0.74
SCHEMBL7380304 0.74 BRD4 (0.39)
Hydrochloric Acid SCHEMBL909236 0.74
Hydrochloric Acid SCHEMBL11837161 0.72 ALDH1A1 (0.37)
Bicarbonate SCHEMBL11614673 0.70 TSHR (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3957771-A PHOSPHINIC ACID CHLORIDES, ALCOHOLS, HYDROLYSIS HOECHST AKTIENGESELLSCHAFT (DT) 1976-05-18 US claimed
JP-1305081-A None JP disclosed
EP-3932915-A1 ACRYLOYL-CONTAINING NUCLEAR TRANSPORT REGULATOR AND USES THEREOF Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) 2022-01-05 EP disclosed
US-20210053945-A1 ACRYLOYL-CONTAINING NUCLEAR TRANSPORT REGULATORS AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2021-02-25 US disclosed
EP-3274352-B1 HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR Bayer Pharma AG (DE) 2019-01-02 EP disclosed
US-9434740-B2 Taxane compounds, compositions and methods ODONATE THERAPEUTICS, LLC (US) 2016-09-06 US disclosed
EP-2170059-B1 CETP INHIBITORS DERIVED FROM BENZOXAZOLE ARYLAMIDES MERCK SHARP & DOHME (US) 2014-11-19 EP disclosed
US-8324198-B1 Monocarbams PFIZER INC. (US) 2012-12-04 US disclosed
US-20120289455-A1 Monocarbams PFIZER INC. 2012-11-15 US disclosed
US-8252782-B2 Monocarbams PFIZER INC. (US) 2012-08-28 US disclosed
EP-0116432-A2 Improvements in or relating to N-(substituted-methyl)-azetidin-2-ones THE UNIVERSITY OF NOTRE DAME DU LAC (US) 1984-08-22 EP disclosed
EP-0114128-A1 3-Amino-2-oxo-azetidine derivatives containing in position 1 a nitrogen heterocyclic radical, process for their preparation, their use as therapeutical agents and intermediates for their preparation ROUSSEL-UCLAF (FR) 1984-07-25 EP disclosed
US-4421686-A 4-Norbornyl-sulfonyl azetidinone intermediates and process for preparing (S)-3-acylamino-4-substituted-2-azetidinones E. R. SQUIBB & SONS, INC. (US) 1983-12-20 US disclosed
EP-0062876-A1 2-Oxo-1-(((substituted sulfonyl)amino)carbonyl)azetidines E.R. Squibb &amp; Sons, Inc. (US) 1982-10-20 EP disclosed
EP-0060119-A1 Azetidinone compounds and their preparation ELI LILLY AND COMPANY (US) 1982-09-15 EP disclosed
US-4304718-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-12-08 US disclosed
US-4181800-A ANTIBIOTICS FROM SUBSTITUTED PERHYDRO-S-TRIAZINES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-01-01 US disclosed
US-4085100-A Intermediate for dephthaloylation of azetidinone compounds SMITHKLINE CORPORATION (US) 1978-04-18 US disclosed
US-4085100-A Intermediate for dephthaloylation of azetidinone compounds SMITHKLINE CORPORATION (US) 1978-04-18 US disclosed
US-3957771-A PHOSPHINIC ACID CHLORIDES, ALCOHOLS, HYDROLYSIS HOECHST AKTIENGESELLSCHAFT (DT) 1976-05-18 US disclosed